Skip navigation
  •  Inicio
  • UDC 
    • Cómo depositar
    • Políticas do RUC
    • FAQ
    • Dereitos de Autor
    • Máis información en INFOguías UDC
  • Percorrer 
    • Comunidades
    • Buscar por:
    • Data de publicación
    • Autor
    • Título
    • Materia
  • Axuda
    • español
    • Gallegan
    • English
  • Acceder
  •  Galego 
    • Español
    • Galego
    • English
  
Ver ítem 
  •   RUC
  • Facultade de Ciencias da Saúde
  • Investigación (FCS)
  • Ver ítem
  •   RUC
  • Facultade de Ciencias da Saúde
  • Investigación (FCS)
  • Ver ítem
JavaScript is disabled for your browser. Some features of this site may not work without it.

Proteomic applications in the study of human mesenchymal stem cells

Thumbnail
Ver/abrir
Arufe2014-proteomes2010053.pdf (722.5Kb)
Use este enlace para citar
http://hdl.handle.net/2183/18446
Creative Commons Attribution 3.0 International License (CC-BY 3.0)
A non ser que se indique outra cousa, a licenza do ítem descríbese como Creative Commons Attribution 3.0 International License (CC-BY 3.0)
Coleccións
  • Investigación (FCS) [1293]
Metadatos
Mostrar o rexistro completo do ítem
Título
Proteomic applications in the study of human mesenchymal stem cells
Autor(es)
Mateos, Jesús
Arufe, M.C.
Fernández-Pernas, Pablo
Fafián Labora, Juan Antonio
Blanco García, Francisco J
Data
2014-02-07
Cita bibliográfica
Mateos J, Pernas PF, Labora JF, Blanco F, Arufe MD. Proteomic Applications in the Study of Human Mesenchymal Stem Cells. Proteomes. 2014 Feb 7;2(1):53-71.
Resumo
Mesenchymal stem cells (MSCs) are undifferentiated cells with an unlimited capacity for self-renewal and able to differentiate towards specific lineages under appropriate conditions. MSCs are, a priori, a good target for cell therapy and clinical trials as an alternative to embryonic stem cells, avoiding ethical problems and the chance for malignant transformation in the host. However, regarding MSCs, several biological implications must be solved before their application in cell therapy, such as safe ex vivo expansion and manipulation to obtain an extensive cell quantity amplification number for use in the host without risk accumulation of genetic and epigenetic abnormalities. Cell surface markers for direct characterization of MSCs remain unknown, and the precise molecular mechanisms whereby growth factors stimulate their differentiation are still missing. In the last decade, quantitative proteomics has emerged as a promising set of techniques to address these questions, the answers to which will determine whether MSCs retain their potential for use in cell therapy. Proteomics provides tools to globally analyze cellular activity at the protein level. This proteomic profiling allows the elucidation of connections between broad cellular pathways and molecules that were previously impossible to determine using only traditional biochemical analysis. However; thus far, the results obtained must be orthogonally validated with other approaches. This review will focus on how these techniques have been applied in the evaluation of MSCs for their future applications in safe therapies.
Palabras chave
Mesenchymal stem cell
Proteomic analysis
Characterization
Differentiation
 
Versión do editor
http://dx.doi.org/10.3390/proteomes2010053
Dereitos
Creative Commons Attribution 3.0 International License (CC-BY 3.0)
ISSN
2227-7382

Listar

Todo RUCComunidades e colecciónsPor data de publicaciónAutoresTítulosMateriasGrupo de InvestigaciónTitulaciónEsta colecciónPor data de publicaciónAutoresTítulosMateriasGrupo de InvestigaciónTitulación

A miña conta

AccederRexistro

Estatísticas

Ver Estatísticas de uso
Sherpa
OpenArchives
OAIster
Scholar Google
UNIVERSIDADE DA CORUÑA. Servizo de Biblioteca.    DSpace Software Copyright © 2002-2013 Duraspace - Suxestións